This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/29/15 - 9:33:05 AM ET (BATS BZX Real-time Price)
Div Yield: --
VVUS Day's Range
VVUS 52 Week Range
VVUS Business Summary
VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union.View VVUS key stats
Vivus - VVUS - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Vivus as a
Sell with a ratings score of D-.
Report Snippet: We rate VIVUS INC (VVUS) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, generally disappointing historical performance in the stock itself and generally high debt management risk.